For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Search Close Search
Page Menu

Gang Han, PhD

Research Focus - Nanoparticles for Cancer Imaging and Therapy

  • Developing nanooptogenetic immunotherapy for tumor treatment
  • Developing clearable nanoparticles for tumor optical and MRI imaging
  • Developing nanoparticles to address the multi-drug resistance of tumors
  • Developing nanoparticles for tumor specific drug and gene delivery

Representative Publication

Nguyen, N.T., Huang, K., Zeng, H. et al. Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety. Nat. Nanotechnol. 16, 1424–1434 (2021). https://doi.org/10.1038/s41565-021-00982-5

Read Publication

More Publications

In the News

Getting Results…
  • Gang Han elected to 2022 Class of the AIMBE College of Fellows
    Research News

    Gang Han elected to American Institute for Medical and Biological Engineering College of Fellows

    In recognition of creative advances in the development of nanomaterials for biophotonic application, Gang Han, PhD, has been elected by the American Institute for Medical and Biological Engineering to its College of Fellows.

    Read more
  • Han lab developing light-activated immune cell therapy for cancers
    Research News

    Han lab developing light-activated immune cell therapy for cancers

    Gang Han, PhD, said newly developed nano-optogenetic immunotherapy represents a new generation of personalized cancer treatment, in which precise control of the timing, location and dosage of T cell activation could be tailored to an individual patient.

    Read more